Top

BY Nicholas Almanza

Testing for BRCA1 and BRCA2 seeks to identify mutations associated with increased risk of developing certain cancers over a person’s lifetime (primarily breast and ovarian cancers in women and breast and prostate cancers in men). Researchers suspect inherited mutations are associated with 5 to 10 percent of all cancers. National guidelines exist to determine which patients with cancer should receive an evaluation for hereditary cancer...

Dr. Karen Lu and genetic counselor Erica Bednar

BY Clayton R. Boldt, Ph.D.

Through in-depth retrospective analysis of data from more than 36,000 patients, a new study led by researchers at The University of Texas...

BY Ron Gilmore

Whether it is new clinical trials for pediatric cancers or programs designed to increase access to smoking cessation programs for low-income...

BY Clayton R. Boldt, Ph.D.

Neoadjuvant therapy is treatment, such as chemotherapy or radiation, given before a patient has surgery. This approach is used in many cancer types to treat microscopic disease that has spread to other organs (micro-metastases) or shrink the primary tumor before proceeding with surgical removal. However, this approach has not been widely adopted in the community when treating patients with pancreatic cancer.

Over the past two decades...

Eugene Koay, M.D., Ph.D., assistant professor of Radiation Oncology

BY Clayton R. Boldt, Ph.D.

Chronic lymphocytic leukemia (CLL), which originates in white blood cells known as lymphocytes, is the most common form of leukemia in adults...

BY MD Anderson staff

This is the second part of Cancer Frontline’s interview with Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology...

BY MD Anderson staff

In October 2018, the Nobel Prize in Physiology or Medicine was awarded to Jim Allison, Ph.D., chair of Immunology, for his discoveries on...

BY Clayton R. Boldt, Ph.D.

It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...

BY Clayton R. Boldt, Ph.D.

Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United States,...

BY Clayton R. Boldt, Ph.D.

MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance...